News
From Molecule to Platform: What the Abogen–Novartis Deal Means for mRNA Innovation
As mRNA therapeutics move into new disease areas, the next challenge is turning promising science into scalable, reproducible development process...
Phase 3 Victory for First Individualized mRNA Cancer Vaccine: What Solutions Are Needed for the New Era of mRNA Therapeutics?
On August 19, 2026, monumental news capable of entering the annals of oncology history arrived: Moderna and Merck jointly announced that the Phase ...
Cancer Cell (IF 44.5) | Tumor Cells Resist Immune Checkpoint Therapy via Macrophage Efferocytosis-Mediated Fatty Acid Recycling
Source: Liang Z, Long X, Wong PP, et al. Tumor cells metabolically resist immune-checkpoint therapy by macrophage efferocytosis-mediated fatty acid...
From Research to Regulatory Practice: Advancing NAT-Based Mycoplasma Testing for Biologics
Mycoplasma contamination remains one of the most persistent safety concerns throughout biologics manufacturing—from cell banking and viral vector ...
Fast, Accurate, and Reliable Molecular Diagnostic Solutions for Nipah Virus Surveillance
Urgent Alert: Nipah Virus Outbreak in India
A recent Nipah virus (NiV) outbreak in West Bengal, India has triggered emergency public health resp...
Exciting News! Yeasen’s GMP-Grade UltraAAV PEI Transfection Reagent Achieves FDA DMF Registration
Yeasen Biotechnology has officially received confirmation from the U.S. Food and Drug Administration (FDA): our UltraAAV PEI Transfection Reagent–G...
Synthesis of siRNA and the Role of T4 RNA Ligase 2
Small interfering RNA (siRNA) is a powerful tool in molecular biology, widely used for gene silencing through RNA interference (RNAi). These short,...
Yeasen Groundbreaking Milestone in High Temperature Bst DNA Polymerase Evolution for Eliminating False Positive Issues in LAMP Assays
Published in ACS Catalysis
Loop-mediated isothermal amplification (LAMP) is a powerful DNA amplification technique celebrated for its simplicity...
mRNA Technology Breakthrough: Yeasen Reveals the Low-Toxicity and High Translation Secret of T7 RNA Polymerase Mutants
Engineered Enzyme Reduces Harmful dsRNA, Paving the Way for Safer mRNA Therapeutics
Researchers from Yeasen Biotechnology and its subsidiary Molef...
Integrated Nucleic Acid Removal System for Producing UltraClean Low DNA Molecular Enzymes Solutions to Eliminate False Positives
Nucleic acid contamination has long been a significant obstacle in the advancement of molecular diagnostic technologies. As more sensitive diagnost...
Congratulations! Ucello’s Cord Blood-Derived Allogeneic Universal CAR-T Approved by US FDA IND!
Ucello Biotechnology Co., Ltd., a key strategic partner of Yeasen Biotechnology, has independently developed a CD19-targeted chimeric antigen recep...
Sharing the Validation Report of the Double-stranded RNA (dsRNA) ELISA Kit to Promote the Standardization of dsRNA Detection.
Are you looking for a reliable way to detect residual dsRNA during mRNA in vitro transcription? Look no further than The Double-stranded RNA (dsRNA...